The rise and fall of Theranos, in one graphic
Advertisement
Theranos, the blood-testing startup with a $9 billion valuation, has had a turbulent year.
Advertisement
On Wednesday, the company announced major changes, including that its president and chief operating officer Sunny Balwani, who served as CEO and founder Elizabeth Holmes' second-in-command, is retiring.
Here's a review of the events that led up to this point over the last year.
Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More
.png)
Dragan Radovanovic/Business Insider
Next StoryAdvertisement
I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
JNK India IPO allotment – How to check allotment, GMP, listing date and more
Indian Army unveils selfie point at Hombotingla Pass ahead of 25th anniversary of Kargil Vijay Diwas
IndiGo places order for 30 wide-body A350-900 planes
Markets extend gains for 5th session; Sensex revisits 74k
Top 10 tourist places to visit in Darjeeling in 2024
